Drug intelligence / Profile preview

lactium

Development stage
Unknown
Lead developer
Ingredia Dairy Experts
Modality
Peptides, Recombinant Proteins and Enzymes
Administration
Oral
01

Overview

Lactium is a **bioactive decapeptide complex** derived from the hydrolysis of **bovine milk alpha-S1 casein** (milk protein) that contains α-casozepine as its main active component. It is produced via food-grade tryptic hydrolysis and is marketed as a **dietary supplement** for managing stress, anxiety, sleep quality, and stress-related symptoms. Lactium does not possess sedative or addictive effects typical of benzodiazepines and is generally considered safe, with no major side effects reported at recommended dosages. Its **mechanism of action** involves binding to GABA-A receptors at the benzodiazepine site, modulating GABAergic neurotransmission, enhancing relaxation, and reducing stress-induced cortisol levels. It is not a pharmaceutical or prescription medication but a nutraceutical/functional food ingredient. It is used globally in various product formulations and has been tested in multiple clinical studies for stress reduction, sleep disorders, and psychodermatological conditions such as acne vulgaris[1][3][4][6][7].

Brand names
Lactium
Other names
alpha-S1 casein hydrolysatealpha-S-1 casein hydrolysatealpha-S 1 casein hydrolysateα-casozepinemilk protein hydrolysatebovine milk alpha S1 casein hydrolysate
02

Targets

BZD site (GABA-A receptor benzodiazepine site)

Beyond the preview

Go deeper on lactium.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on lactium.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call